B of A cuts Definitive Healthcare to Underperform, target $0.7
B of A Securities analyst Allen Lutz downgraded Definitive Healthcare from Buy to Underperform and lowered the price target from $3.5 to $0.7, signaling a negative outlook for the NASDAQ-listed company.
*this image is generated using AI for illustrative purposes only.
B of A Securities analyst Allen Lutz has downgraded Definitive Healthcare from Buy to Underperform, significantly reducing the outlook for the stock. The firm lowered the price target to $0.7, down from the previous $3.5 target. This revision reflects a bearish shift in the analyst's perspective on the company's future performance.
The downgrade moves the stock from a Buy rating to Underperform, indicating that the analyst expects the shares to lag behind the broader market or industry averages. The substantial reduction in the price target suggests concerns over the company's ability to meet previous expectations.
Rating and Price Target Changes
The following table outlines the revised ratings and price targets for Definitive Healthcare:
| Metric | Previous | New |
|---|---|---|
| Rating | Buy | Underperform |
| Price Target | $3.5 | $0.7 |
Definitive Healthcare is listed on the NASDAQ under the ticker symbol DH.
What specific operational or financial challenges prompted such a drastic reduction in the price target?
How might this downgrade influence other analysts' ratings and overall investor sentiment toward Definitive Healthcare?
What strategic changes could Definitive Healthcare implement to reverse the bearish outlook and regain market confidence?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
